Research in Social and Administrative Pharmacy
Volume 7, Issue 2 , Pages 122-133 , June 2011

New Zealand community pharmacists' views of their roles in meeting medicine-related needs for people with mental illness

  • Keith Crump, M.Pharm.Pract., P.G.Dip.Pub.Health, P.G.Dip.Clin.Pharm., Dip.Pharm., Dip.Strat.Leadership, Reg.Pharm.N.Z.

      Affiliations

    • Waitemata District Health Board, Private Bag 93115, Henderson Auckland, New Zealand
    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Guobin Boo, B.Pharm.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Fung Shin Liew, B.Pharm.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Tracy Olivier, B.Pharm.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Cecilia So, B.Pharm.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Jae Yong Sung, B.Pharm.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Chi Hang Wong, B.Pharm.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • John Shaw, Ph.D., P.G.Dip.Clin.Pharm., B.Sc.(Pharm.)Hons., F.P.S., F.N.Z.C.P., F.R.Pharm.S., Reg.Pharm.N.Z.

      Affiliations

    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • ,
  • Amanda Wheeler, Ph.D., P.G.Dip.Psych.Pharm., B.Pharm., B.Sc., Reg.Pharm.N.Z.

      Affiliations

    • Waitemata District Health Board, Private Bag 93115, Henderson Auckland, New Zealand
    • School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019 New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 9 8381882; fax: +64 9 8381883.

References 

  1. World Health Organization (WHO) . The World Health Report 2001: Mental Health: New Understanding, New Hope. Geneva, Switzerland: WHO; 2001;
  2. World Health Organization . The global burden of disease: 2004 update. Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf2008;Accessed 09.03.2010
  3. Wells JE, Browne MAO, Scott KM, et al. Te Rau Hinengaro: the New Zealand Mental Health Survey: overview of methods and findings. Aust N Z J Psychiatry. 2006;40:835–844
  4. Scott KM, Browne MAO, McGee MA, Wells JE. Mental-physical comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry. 2006;40:882–888
  5. World Health Organization and World Organization of Family Doctors (Wonca) . Integrating mental health into primary care: a global perspective. Available at: http://whqlibdoc.who.int/publications/2008/9789241563680_eng.pdf2008;Accessed 09.03.2010
  6. Wilson J. Mental health services in New Zealand. Int J Law Psychiatry. 2000;23:215–228
  7. World Health Organization . Mental Health Gap Action Programme: scaling up care for mental, neurological and substance use disorders. Available at: http://whqlibdoc.who.int/publications/2008/9789241596206_eng.pdf2008;Accessed 09.03.2010
  8. Mental Health Commission . Our Lives in 2014: A Recovery Vision from People with Experience of Mental Illness for the Second Mental Health Plan and the Development of the Health and Social Sectors. Wellington, New Zealand: Mental Health Commission; 2004;
  9. Keks NA, Altson K, Hope J, et al. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Aust N Z J Psychiatry. 1999;33:896–901
  10. Owen RR, Feng W, Thrush CR, Hudson TJ, Austen MA. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv. 2001;52:1523–1525
  11. Owen RR, Thrush CR, Kirchner JE, Fischer EP, Booth BM. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care. 2000;12:475–482
  12. Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate?. CNS Drugs. 2002;16:99–109
  13. Leslie DL, Rosenheck RA. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector. J Ment Health Policy Econ. 2003;6:113–121
  14. Meagher D, Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull. 2003;27:266–270
  15. Harrington M, Lelliott P, Paton C, Konsolaki M, Sensky T, Okocha C. Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatr Bull. 2002;26:418–420
  16. Paton C, Lelliott P, Harrington M, Okocha C, Sensky T, Duffett R. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol. 2003;17:223–229
  17. Taylor D, Mir S, Kerwin R. Prescribing in schizophrenia. Evaluating the effect of introducing a new treatment protocol. Psychiatr Bull. 2000;24:106–108
  18. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101:119–124
  19. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196–201
  20. Gray R, Wykes T, Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs. 2002;9:277–284
  21. Allen MH, Carpenter D, Sheets JL, Miccio S, Ross R. What do consumers say they want and need during a psychiatric emergency?. J Psychiatr Pract. 2003;9:39–58
  22. Happell B, Manias E, Roper C. Wanting to be heard: mental health consumers' experiences of information about medication. Int J Ment Health Nurs. 2004;13:242–248
  23. Howard PB, El-Mallakh P, Kay Rayens M, Clark JJ. Consumer perspectives on quality of inpatient mental health services. Arch Psychiatr Nurs. 2003;17:205–217
  24. Gray R, Rofail D, Allen J, Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs. 2005;52:31–37
  25. Black E, Murphy AL, Gardner DM. Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv. 2009;60:1123–1127
  26. Maslen CL, Rees L, Redfern PH. Role of the community pharmacist in the care of patients with chronic schizophrenia in the community. Int J Pharm Pract. 1996;4:187–195
  27. Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55:1434–1436
  28. Chapman JL, Zechel A, Carter YH, Abbott S. Systematic review of recent innovations in service provision to improve access to primary care. Br J Gen Prac. 2004;54:374–381
  29. Garfield S, Smith F, Francis SA. From black clouds to lighter grey: how pharmacists can help in depression. Pharm J. 2004;272:576–577
  30. Wagner EH. The role of patient care teams in chronic disease management. Br Med J. 2000;320:569–572
  31. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Health Syst Pharm. 1990;47:533–543
  32. Urbis Keys Young . Evaluation of the Home Medicines Review Program (pharmacy component). Available at: http://www.guild.org.au/uploadedfiles/Medication_Management_Reviews/Overview/Urbis%20Keys%20Young%20evaluation.pdf2005;Accessed 21.12.2009
  33. Shaw J, Seal R, Pilling M. Room for review: a guide to medication review: the agenda for patients, practitioners and managers. Available at: http://www.keele.ac.uk/schools/pharm/npcplus/medicinespartner/documents/room_for_review.pdf2002;Accessed 21.12.2009
  34. Ministry of Health . Towards a New Zealand medicines strategy: consultation document. Available at: http://www.moh.govt.nz/moh.nsf/pagesmh/5633/$File/towards-newzealand-medicines-strategy-consult.pdf2006;Accessed 21.12.2009
  35. District Health Boards New Zealand  DHBNZ Pharmacy Advisory Group. New Zealand National Pharmacist Services Framework: Version 1. Available at: http://www.dhbnz.org.nz/Site/SIG/NPSF/NPSF-Framework.aspx2007;Accessed 21.12.2009
  36. Pharmacy Council of New Zealand . Medicines management. Definition, levels, competence framework [pdf]. Available at: http://www.pharmacycouncil.org.nz/cms_show_download.php?id=442006;Accessed 21.12.2009
  37. Maidment I, Taylor DA, Branford D. “Talking about medicines”—agreeing on the way forward. Hosp Pharmacist. 2007;14:74
  38. Wheeler AJ, Al-Jumaily J, Lee DLW, et al. Knowing what we don't know: a learning needs analysis for CPD in optimal use of medicines in mental health. Pharm J NZ. 2009;2:18–24
  39. Fontana A, Frey JH. The interview: from neural stance to political involvement. In:  Denzin NK,  Lincoln YS editor. Sage Handbook of Qualitative Research. 3rd ed.. London, UK: Sage Publications, Inc.; 2005;p. 695–728
  40. Walker RA, Martin S. Demographic Profile for Waitemata DHB: An Analysis of the 2006 Census. Auckland, New Zealand: Waitemata District Health Board; 2007;
  41. In:  Oakley-Browne M,  Wells J,  Scott K editor. Te Rau Hinengaro: The New Zealand Mental Health Survey. Wellington, New Zealand: Ministry of Health; 2006;
  42. In:  Robson B,  Harris R editor. Hauora: Maori Standards of Health IV. A Study of the Years 2000-2005. Wellington, New Zealand: Te Ropu Rangahau Hauora a Eru Pomare; 2007;
  43. Waitangi Tribunal . Treaty of Waitangi. Available at: http://www.waitangi-tribunal.govt.nz/treaty/meaning.asp2010;Accessed 12.01.2010
  44. Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27:237–246
  45. Ministry of Health . The primary care strategy. Available at: http://www.moh.govt.nz/moh.nsf/0/7BAFAD2531E04D92CC2569E600013D04/$File/PHCStrat.pdf2001;Accessed 12.01.2010
  46. Schneider P, Murphy J, Pedersen C. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc. 2008;48:58–63
  47. Huang H, Maguire M, Miller E, Appel L. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol. 2000;152:780–787
  48. Sleath B, Wurst K, Lowery T. Drug information sources and antidepressant adherence. Comm Mental Health J. 2003;39:359–368
  49. Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41:1962–1970
  50. Crockett J, Taylor S, Grabham A, Stanford P. The Role of the Community Pharmacist in the Management of Depression (Report Prepared for The Pharmacy Guild of Australia). Sydney, Australia: University of Sydney; 2005;
  51. Fenton WS, Blyer CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23:637–651
  52. Garfield S, Francis S, Smith F. Building concordant relationships with patients starting antidepressant medication. Patient Educ Couns. 2004;55:241–246
  53. Airaksinen M, Ahonen R, Enlund H. Customer feedback as a tool for improving pharmacy services. Int J Pharm Pract. 1995;3:219–226
  54. Benson M, Cribb A. In their own words: community pharmacists and their health education role. Int J Pharm Pract. 1995;3:74–77
  55. Matheson C, Bond C. Motivations for and barriers to community pharmacy services for drug misusers. Int J Pharm Pract. 1999;7:256–263
  56. Zweber A. Cultural competence in pharmacy practice. Am J Pharm Educ. 2002;66:172–176
  57. Baxter J, Kokaua J, Wells JE, McGee MA, Browne MAO. Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust NZ J Psychiatry. 2006;40:905–913
  58. Pharmacy Council of New Zealand . Cultural competence standards. Available at: http://www.pharmacycouncil.org.nz/cms_show_download.php,id=572008;Accessed 12.01.2010
  59. Hughes C, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53:600–606
  60. Bell JS, Aslani P, McLachlan AJ, Whitehead P, Chen TF. Mental health case conferences in primary care: content and treatment decision making. Res Soc Adm Pharm. 2007;3:86–103
  61. Scahill S, Harrison J, Sheridan J. The ABC of New Zealand's ten year vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract. 2009;17:135–142
  62. Anderson C. Health promotion by community pharmacists: perceptions, realities and constraints. J Soc Adm Pharm. 1998;15:10–22
  63. Anderson C. Health promotion in community pharmacy: the UK situation. Patient Educ Couns. 2000;39:285–291
  64. Smith W, Ray M, Shannon D. Physicians' expectations of pharmacists. Am J Health Syst Pharm. 2002;59:50–57
  65. Rijcken CAW, van der Veur H, Knegtering H, de Jong-van den Berg LTW. Schizophrenia care and the Dutch community pharmacy: the unmet needs. Int J Pharm Pract. 2003;11:97–104
  66. Guba GE, Lincoln YS. Paradigmatic controversies, contradictions and emerging confluences. In:  Denzin NK,  Lincoln YS editor. Sage Handbook of Qualitative Research. 3rd edn. London, UK: Sage Publications, Inc.; 2005;p. 191–216

PII: S1551-7411(10)00041-0

doi: 10.1016/j.sapharm.2010.03.006

Research in Social and Administrative Pharmacy
Volume 7, Issue 2 , Pages 122-133 , June 2011

Article Tools

* Image Usage & Resolution